Presence and activity of Fibrinogen like protein 2 in platelets
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0285735 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Izhack Cherny und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hemato-Oncology Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Isr…. Hauptthemen laut MEDLINE: Thrombin, Thromboplastin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Office of the Chief Scientist, Ministry of Health.
Abstract (Originalsprache)
Background
Fibrinogen-like protein 2 (FGL2) is a serine protease capable of converting prothrombin into thrombin ( i . e ., prothrombinase-like activity) while bypassing the classic coagulation cascade. It has been reported to be expressed by mononuclear blood cells and endothelial cells. There are multiple reports that FGL2 supports tumor development and metastasis. However, in the blood, the origin and functional significance of FGL2 has not been established.
Objective
To determine if FGL2, a malignancy related enzyme, is present in platelets.
Methods
Peripheral blood samples were collected in K 2 EDTA tubes. Blood cells and platelets were separated and thoroughly washed to produce plasma-free samples. Procoagulant activity was measured in the cell lysates using a thrombin generation test or an adjusted prothrombin time (PT) test in plasma deficient of factor X. The findings were further supported by confocal microscopy, immunoprecipitation, flow cytometry, enzyme-linked immunosorbent assays and specific inhibition assays.
Results
FGL2 protein was readily detected in platelets. Also, despite being expressed by lymphocytes, FGL2 prothrombinase-like activity was solely detected in platelet samples, but not in white blood cell samples. Quiescent platelets were shown to contain the FGL2 protein in an active form. Upon activation, platelets secreted the active FGL2 into the milieu.
Conclusions
Active FGL2 is found in platelets. This suggests another role for the involvement of platelets in malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hemato-Oncology Laboratory, Felsenstein Medical Research Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Hematology Laboratory, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
- Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
ORCID-Profile: Esther Rabizadeh
Förderung
- Office of the Chief Scientist, Ministry of Health
Zitieren
APA
Cherny, I., Hasin, P., Philosoph, L. K., Shahal-Zimra, Y., Gurion, R., & Rabizadeh, E. (2023). Presence and activity of Fibrinogen like protein 2 in platelets. PLOS ONE. https://doi.org/10.1371/journal.pone.0285735
Vancouver
Cherny I, Hasin P, Philosoph LK, Shahal-Zimra Y, Gurion R, Rabizadeh E. Presence and activity of Fibrinogen like protein 2 in platelets. PLOS ONE. 2023. doi:10.1371/journal.pone.0285735
BibTeX
@article{Cherny2023,
author = {Cherny, Izhack and Hasin, Pinhas and Philosoph, Lital Kalich and Shahal-Zimra, Yael and Gurion, Ronit and Rabizadeh, Esther},
title = {Presence and activity of Fibrinogen like protein 2 in platelets},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0285735}
}
EUVIMED